List of Next-Gen Sequencing Companies in Washington - 8

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test; and Amgen to develop a therapeutic to prevent or treat COVID-19. It serves the life sciences research, clinical diagnostics, and drug discovery customers. Adaptive Biotechnologies Corporation has a translational collaboration with AstraZeneca to investigate the use of immunoSEQ T-MAP. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.

Advanced Cellular Dynamics (ACD) is a world-leader in the production, provision and application of novel cell-based assay systems. Our capabilities provide us with a unique capability to explore a variety of biological entities and systems. We have deep-rooted expertise in kinases, GPCRs, ion channels and transcription factors - to name a few. Those skills are applied to a variety of experimental systems that include (but aren't limited to) oncology, immunology and neurobiology. We also leverage these skills to provide our global clientele with contract research services. Whether you want to disrupt a specific gene in stem cells, or create a new biological cell-based assay in your tissue/cell line of choice, we have the knowledge and skills to help you succeed!

Allele Diagnostics, Inc., located in Spokane, WA, was established in 2014 to offer superior genetic testing services. We feel that high-quality testing, reporting, and services can be offered to you with quick results. We pride ourselves in being a laboratory that offers the genetic counseling services clinicians need in a genetic testing company. We combine this service with reliable, fast, accurate test results provided to you via user-friendly and conveniently accessible reports. At Allele Diagnostics, we are passionate about providing reliable answers as quickly and accurately as possible. We continuously strive to improve the efficiency of our workflow and improve the quality of our test results. We encourage feedback from our clients on how we can improve or assist in bringing your ideas into a clinical testing environment. Utilizing our extensive experience in genetic testing, we can work with you to develop solutions to the challenges you have previously experienced in receiving fast, accurate results. Additionally, we are always looking for new and better ways to provide answers to genetic questions and are continuously evaluating novel technologies to see how they can fit into our laboratory given the rapidly evolving clinical genetic testing space. Allele Diagnostics is a CLIA and CAP certified clinical laboratory committed to providing superior testing services for the best patient care possible. We are currently licensed in California, Florida, and Pennsylvania and are pursuing various other state specific licenses.

Amplicon independently validates all COVID19 IgM/IG Rapid Tests offered. In business since 1996, Amplicon proactively performs investigational research to confirm the claims of all manufacturers. Doing our due diligence is a critical part of bringing the best performing tests to Medical Professionals. To learn more, please visit https://covid19.ampliconexpress.com/

Matchstick’s premier product, PIXUL (forPIXelatedULtrasound), is a tool that processes each and every well of a 96-well microplate consistently and quickly.

Resolution Bioscience, a part of Agilent, is pioneering next generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy. Our proprietary molecular analytics platform interrogates cell-free DNA for actionable information that, until now, has only been accessible through invasive biopsy procedures. We have developed over 50 focused panels and are currently working on companion diagnostics to support therapeutic approvals. We are dedicated to improving cancer outcomes through a suite of clinical tests to guide selection of targeted therapies and monitor their effectiveness over time.

Scisco Genetics Inc, a Seattle-based spin-off from the Fred Hutchinson Cancer Research Center, is a leading provider of sequencing services and products for genotyping the immune system.

Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits. They’re using cutting-edge sequencing technology, statistical genetics, and machine learning to identify entirely new therapeutic targets.